Vor Ort
Merkzettel Warenkorb
  • Produktbild: In-Patient Treatment for Alcoholism
  • Produktbild: In-Patient Treatment for Alcoholism

In-Patient Treatment for Alcoholism A Multi-Centre Evaluation Study

97,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

16.12.2011

Verlag

Springer Berlin

Seitenzahl

381

Maße (L/B/H)

24,2/17/2,2 cm

Gewicht

681 g

Auflage

Softcover reprint of the original 1st ed. 1989

Übersetzt von

F.K.H. Wagstaff

Sprache

Englisch

ISBN

978-3-642-74390-0

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

16.12.2011

Verlag

Springer Berlin

Seitenzahl

381

Maße (L/B/H)

24,2/17/2,2 cm

Gewicht

681 g

Auflage

Softcover reprint of the original 1st ed. 1989

Übersetzt von

F.K.H. Wagstaff

Sprache

Englisch

ISBN

978-3-642-74390-0

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: In-Patient Treatment for Alcoholism
  • Produktbild: In-Patient Treatment for Alcoholism
  • 1 Introduction.- 1.1 Aim of the Study.- 1.2 Review of the Literature.- 2 Method.- 2.1 Basic Model.- 2.2 Structure of the Study.- 2.2.1 Design.- 2.2.2 Selection of Treatment Centres.- 2.2.3 Description of Treatment Centres.- 2.3 Selection of Patients.- 2.4 Patient Variables.- 2.4.1 Sociodemographic Data.- 2.4.2 Social Behaviour.- 2.4.3 Life Events and Stress.- 2.4.4 Drinking Behaviour and Patients’ Attitudes to It.- 2.4.5 Complaints and Alcohol-Related Illnesses.- 2.4.6 Personality Traits.- 2.4.7 Attitudes to Treatment.- 2.4.8 Experiences of Therapy.- 2.5 Assessing the Outcome of Treatment.- 2.5.1 Drinking Behaviour and Use of Other Addictive Substances.- 2.5.2 Physical Health.- 2.5.3 Social Integration.- 2.5.4 Personality.- 2.6 Study Procedure.- 2.6.1 Data Recorded at Admission and Discharge.- 2.6.2 Data Recorded at 6- and 18-Month Follow-Up.- 2.7 Data Protection.- 2.8 Data Evaluation.- 3 Treatment Centres.- 3.1 Description.- 3.1.1 Size.- 3.1.2 Staffing.- 3.1.3 Admission Criteria.- 3.1.4 Goals of Treatment.- 3.1.5 General Description of Treatment.- 3.1.6 Particular Aspects of Therapy.- 3.2 Factors in the Therapeutic Atmosphere.- 3.2.1 Introduction.- 3.2.2 Method.- 3.2.3 Reliability of K-SEKT.- 3.2.4 Importance of Factors in the Therapeutic Atmosphere (K-SEKT-A).- 3.2.5 Implementation of Factors in the Therapeutic Atmosphere (K-SEKT-B).- 3.2.6 Comparison of K-SEKT-A and K-SEKT-B.- 3.3 Summary.- 4 Admission Data.- 4.1 Data Collection.- 4.2 Sociodemographic Data.- 4.3 Use of Addictive Substances.- 4.3.1 Drinking Behaviour.- 4.3.2 Medicaments and Drugs.- 4.4 Personality and Social Behaviour.- 4.4.1 Personality: Freiburg Personality Inventory.- 4.4.2 Social Behaviour: Self-Assertiveness Questionnaire.- 4.4.3 Psychosocial Problems.- 4.5 Physical Condition.- 4.6 Previous Treatment for Alcoholism.- 4.7 Attitudes to Treatment (EZB).- 4.8 Life Events (LEL).- 4.9 Summary.- 5 Discharge Data.- 5.1 Data Collection.- 5.2 Sociodemographic Data.- 5.3 Behaviour and Symptoms During Treatment.- 5.3.1 Drop-Outs.- 5.3.2 Relapses.- 5.3.3 Changes in Patients’ Attitudes to Their Drinking Behaviour.- 5.3.4 Secondary Psychiatric Diagnoses and Other Symptoms.- 5.3.5 Participation of Patients and Significant Persons in Treatment.- 5.3.6 Clinical Prognosis.- 5.4 Personality Changes.- 5.4.1 Freiburg Personality Inventory.- 5.4.2 Self-Assertiveness Questionnaire.- 5.4.3 Interpretation.- 5.5 Summary.- 6 Six-Month Follow-Up.- 6.1 Data Collection.- 6.2 Sociodemographic Data.- 6.3 Use of Addictive Substances.- 6.3.1 Alcohol.- 6.3.2 Medicaments.- 6.3.3 Smoking.- 6.3.4 Interpretation and Conclusions.- 6.4 Personality Changes.- 6.4.1 Freiburg Personality Inventory.- 6.4.2 Self-Assertiveness Questionnaire.- 6.5 Physical Condition.- 6.6 Life Events.- 6.7 Treatment During the First 6 Months After Discharge.- 6.7.1 Psychotherapy.- 6.7.2 In-Patient Treatment.- 6.7.3 Interpretation and Conclusions.- 6.8 Comparison of Some Outcome Criteria.- 6.9 Summary.- 7 Eighteen-Month Follow-Up.- 7.1 Data Collection.- 7.2 Sociodemographic Data.- 7.3 Use of Addictive Substances.- 7.3.1 Alcohol.- 7.3.2 Other Addictive Substances.- 7.3.3 Diagnoses of Secondary Abuse of or Dependence on Medicaments or Drugs.- 7.4 Personality and Social Behaviour.- 7.4.1 Freiburg Personality Inventory.- 7.4.2 Selected Complaints.- 7.4.3 Self-Assertiveness Questionnaire.- 7.5 Physical Condition and Complaints.- 7.6 Life Events.- 7.7 Treatment During the Follow-Up Period.- 7.7.1 Self-Help Groups and Out-Patient Treatment.- 7.7.2 In-Patient Treatment.- 7.8 Comparison of Different Outcome Criteria.- 7.9 Summary.- 8 Data from Health and Pension Insurance Institutions.- 8.1 Health Insurance Companies.- 8.1.1 Data Collection.- 8.1.2 Method.- 8.1.3 Results.- 8.2 Pension Insurance Institutions.- 8.2.1 Data Collection.- 8.2.2 Results.- 8.3 Summary.- 8.3.1 Health Insurance Companies.- 8.3.2 Pension Insurance Institutions.- 9 Reliability and Validity of Data.- 9.1 Heterogeneity of Data.- 9.2 Results.- 9.2.1 Comparison of Interviews with Written Follow-Up.- 9.2.2 Comparison of Data at 6-Month and 18-Month Follow-Up.- 9.2.3 Comparison with Data given by Significant Others.- 9.2.4 Comparison with Data from the Health Insurance Companies.- 9.2.5 Comparison of a Patient Sample with a High Refusal Rate and the Anonymous, Unselected Sample.- 9.2.6 Factors in the Patient Group Without 18-Month Follow-Up Data.- 9.3 Summary.- 10 Changes Over the Course of the Study.- 10.1 Alcohol Abstinence.- 10.2 Marital Status, Living Arrangements and Work.- 10.2.1 Marital Status and Living Arrangements.- 10.2.2 Work and Retirement.- 10.3 Changes In and Interactions Between Outcome Criteria.- 10.3.1 Introduction.- 10.3.2 Unemployment and Abstinence.- 10.3.3 Other Outcome Criteria and Abstinence.- 10.4 Changes in Personality and Social Behaviour.- 10.4.1 Freiburg Personality Inventory.- 10.4.2 Self-Assertiveness Questionnaire.- 10.5 Drop-Outs from Treatment, Length of Treatment and Outcome.- 10.6 Summary.- 11 Patients’ Attitudes to and Experiences of Treatment.- 11.1 Attitudes to Treatment (EZB).- 11.1.1 Theoretical Background.- 11.1.2 Results.- 11.2 Patients’ Experiences of Therapy (TEL).- 11.2.1 Theoretical Background.- 11.2.2 Comparison of Treatment Experiences at Discharge and 6-Month Follow-Up.- 11.2.3 Univariate Item Selection.- 11.2.4 Multivariate Item Selection.- 11.2.5 TEL Scales and Outcome Criteria.- 11.3 Correlation Between EZB and TEL.- 11.4 Summary.- 12 Patient Variables as Prognostic Factors.- 12.1 Introduction.- 12.1.1 Selection of Criteria for Prognosis.- 12.1.2 Time and Range of Prognosis.- 12.1.3 Selection of Variables on Which to Base a Prognosis.- 12.1.4 General and Special (Treatment-Related) Prognostic Factors.- 12.1.5 Reliability and Validity of Prognostic Factors.- 12.1.6 Single Variables vs. Combinations as Prognostic Factors.- 12.2 Method.- 12.2.1 Procedure.- 12.2.2 Selection Criterion.- 12.3 Prognostic Factors for Drinking Behaviour.- 12.3.1 Admission Data.- 12.3.2 Discharge Data.- 12.4 Prognostic Factors for Other Outcome Criteria.- 12.4.1 Prognosis Index and Other Outcome Criteria.- 12.4.2 Clinical Prognosis vs. Statistical Prognosis.- 12.4.3 Time When the Prognosis Is Made.- 12.5 Analysis of Variables and Constructs of Special Clinical Relevance.- 12.5.1 Age.- 12.5.2 Severity of Alcoholism.- 12.5.3 Previous Treatment in an Addiction Unit.- 12.6 Prognostic Significance of Dropping Out.- 12.6.1 Reasons for Dropping Out Related to Abstinence.- 12.6.2 Time in Treatment Before Dropping Out.- 12.6.3 Factors Predictive of Dropping Out.- 12.7 Summary.- 13 Treatment Variables.- 13.1 Introduction.- 13.2 Grouping of Treatment Variables and Treatment Centres.- 13.2.1 Factor Analysis.- 13.2.2 Cluster Analysis.- 13.3 Treatment Variables and Outcome.- 13.3.1 Method.- 13.3.2 Treatment Effects of Index Treatment.- 13.4 Effect of the Length of Treatment.- 13.4.1 Starting Point and Procedure.- 13.4.2 Approach 1: Matching.- 13.4.3 Approach 2: Logit Analysis.- 13.4.4 Approach 3: Analysis of the Centres.- 13.4.5 Other Outcome Criteria.- 13.4.6 Intercorrelation Between Length and Other Features of Treatment.- 13.4.7 Interpretation and Conclusions.- 13.5 Effects of After-Care in the Follow-Up Period.- 13.5.1 Influence of Self-Help Groups.- 13.5.2 Attendance at Self-Help Groups and Index Treatment Variables.- 13.6 Summary.- 14 Indication.- 14.1 Introduction.- 14.2 Indication for Length of Treatment.- 14.3 Method.- 14.3.1 Preliminary Assessments.- 14.3.2 Final Procedure.- 14.4 Results for Men.- 14.4.1 Poor Prognosis Group.- 14.4.2 Moderate Prognosis Group.- 14.4.3 Good Prognosis Group.- 14.5 Indication Model for Men.- 14.5.1 Poor Prognosis Group.- 14.5.2 Moderate Prognosis Group.- 14.5.3 Good Prognosis Group.- 14.5.4 Summary of Optimization of Abstinence in Men.- 14.6 Results for Women.- 14.6.1 Negative Prognosis Group.- 14.6.2 Positive Prognosis Group.- 14.7 Indication Model for Women.- 14.7.1 Negative Prognosis Group.- 14.7.2 Positive Prognosis Group.- 14.7.3 Summary of Optimization of Abstinence in Women.- 14.8 Prognosis and Indication.- 14.9 Summary.- 14.9.1 Results for Men.- 14.9.2 Results for Women.- 15 Other Factors Influencing Outcome.- 15.1 Influence Factors in After-Care and After-Treatment.- 15.1.1 Self-Help Groups and Treatment Outcome.- 15.1.2 Out-Patient Psychotherapy and Treatment Outcome.- 15.2 Influence Factors in the Social Environment.- 15.3 Network of Influence Factors and Treatment Outcome.- 15.4 Summary.- 16 Discussion.- 16.1 Methodology.- 16.1.1 Type of Study.- 16.1.2 Reliability and Validity of Data.- 16.1.3 Evaluation Procedure.- 16.2 Results of the Individual Data Collections.- 16.2.1 Description of Treatment.- 16.2.2 Description of the Patient Sample.- 16.2.3 Discharge.- 16.2.4 Follow-Up at 6 and 18 Months.- 16.3 Patients’ Attitudes to and Experiences of Treatment.- 16.3.1 Attitudes to Treatment (EZB).- 16.3.2 Experiences of Treatment (TEL).- 16.4 Prognosis.- 16.4.1 Methodological Problems.- 16.4.2 Individual Prognostic Factors.- 16.4.3 Prognosis of Particular Subgroups.- 16.5 Treatment Variables.- 16.5.1 Reduction of the Number of Treatment Variables.- 16.5.2 Discussion of Methods and General Comments.- 16.5.3 Individual Treatment Variables.- 16.5.4 Length of Treatment.- 16.6 Indication.- 16.7 Influence Factors After Index Treatment.- References.- Appendices.